153 related articles for article (PubMed ID: 24927330)
21. Increased CD147 (EMMPRIN) expression in the rat brain following traumatic brain injury.
Wei M; Li H; Shang Y; Zhou Z; Zhang J
Brain Res; 2014 Oct; 1585():150-8. PubMed ID: 24968091
[TBL] [Abstract][Full Text] [Related]
22. Matrix metalloproteinase 2 is associated with stable and matrix metalloproteinases 8 and 9 with vulnerable carotid atherosclerotic lesions: a study in human endarterectomy specimen pointing to a role for different extracellular matrix metalloproteinase inducer glycosylation forms.
Sluijter JP; Pulskens WP; Schoneveld AH; Velema E; Strijder CF; Moll F; de Vries JP; Verheijen J; Hanemaaijer R; de Kleijn DP; Pasterkamp G
Stroke; 2006 Jan; 37(1):235-9. PubMed ID: 16339461
[TBL] [Abstract][Full Text] [Related]
23. Extracellular matrix metalloproteinase inducer regulates metalloproteinases in human uterine endometrium.
Braundmeier AG; Fazleabas AT; Lessey BA; Guo H; Toole BP; Nowak RA
J Clin Endocrinol Metab; 2006 Jun; 91(6):2358-65. PubMed ID: 16522689
[TBL] [Abstract][Full Text] [Related]
24. Urine matrix metalloproteinases and their extracellular inducer EMMPRIN in children with chronic kidney disease.
Musiał K; Bargenda A; Zwolińska D
Ren Fail; 2015 Jul; 37(6):980-4. PubMed ID: 25945606
[TBL] [Abstract][Full Text] [Related]
25. Matrix metalloproteinase induction by EMMPRIN in experimental focal cerebral ischemia.
Burggraf D; Liebetrau M; Martens HK; Wunderlich N; Jäger G; Dichgans M; Hamann GF
Eur J Neurosci; 2005 Jul; 22(1):273-7. PubMed ID: 16029217
[TBL] [Abstract][Full Text] [Related]
26. Cytokines regulate matrix metalloproteinases in human uterine endometrial fibroblast cells through a mechanism that does not involve increases in extracellular matrix metalloproteinase inducer.
Braundmeier AG; Nowak RA
Am J Reprod Immunol; 2006 Sep; 56(3):201-14. PubMed ID: 16911716
[TBL] [Abstract][Full Text] [Related]
27. Extracellular matrix metalloproteinase inducer regulates matrix metalloproteinase activity in cardiovascular cells: implications in acute myocardial infarction.
Schmidt R; Bültmann A; Ungerer M; Joghetaei N; Bülbül O; Thieme S; Chavakis T; Toole BP; Gawaz M; Schömig A; May AE
Circulation; 2006 Feb; 113(6):834-41. PubMed ID: 16461815
[TBL] [Abstract][Full Text] [Related]
28. The impact of differential expression of extracellular matrix metalloproteinase inducer, matrix metalloproteinase-2, tissue inhibitor of matrix metalloproteinase-2 and PDGF-AA on the chronicity of venous leg ulcers.
Mwaura B; Mahendran B; Hynes N; Defreitas D; Avalos G; Adegbola T; Adham M; Connolly CE; Sultan S
Eur J Vasc Endovasc Surg; 2006 Mar; 31(3):306-10. PubMed ID: 16169261
[TBL] [Abstract][Full Text] [Related]
29. Ventilator-induced lung injury upregulates and activates gelatinases and EMMPRIN: attenuation by the synthetic matrix metalloproteinase inhibitor, Prinomastat (AG3340).
Foda HD; Rollo EE; Drews M; Conner C; Appelt K; Shalinsky DR; Zucker S
Am J Respir Cell Mol Biol; 2001 Dec; 25(6):717-24. PubMed ID: 11726397
[TBL] [Abstract][Full Text] [Related]
30. Extracellular matrix metalloproteinase inducer stimulates tumor angiogenesis by elevating vascular endothelial cell growth factor and matrix metalloproteinases.
Tang Y; Nakada MT; Kesavan P; McCabe F; Millar H; Rafferty P; Bugelski P; Yan L
Cancer Res; 2005 Apr; 65(8):3193-9. PubMed ID: 15833850
[TBL] [Abstract][Full Text] [Related]
31. The temporal expression and localization of extracellular matrix metalloproteinase inducer (EMMPRIN) during the development of periodontitis in an animal model.
Liu L; Li C; Cai X; Xiang J; Cao Z; Dong W
J Periodontal Res; 2010 Aug; 45(4):541-9. PubMed ID: 20412416
[TBL] [Abstract][Full Text] [Related]
32. Extracellular matrix metalloproteinase inducer (CD147) is a novel receptor on platelets, activates platelets, and augments nuclear factor kappaB-dependent inflammation in monocytes.
Schmidt R; Bültmann A; Fischel S; Gillitzer A; Cullen P; Walch A; Jost P; Ungerer M; Tolley ND; Lindemann S; Gawaz M; Schömig A; May AE
Circ Res; 2008 Feb; 102(3):302-9. PubMed ID: 18048771
[TBL] [Abstract][Full Text] [Related]
33. Immunolocalization of matrix metalloproteinases-2 and -9 during apical periodontitis development.
Corotti MV; Zambuzzi WF; Paiva KB; Menezes R; Pinto LC; Lara VS; Granjeiro JM
Arch Oral Biol; 2009 Aug; 54(8):764-71. PubMed ID: 19497558
[TBL] [Abstract][Full Text] [Related]
34. Expression of EMMPRIN in adenoid cystic carcinoma of salivary glands: correlation with tumor progression and patients' prognosis.
Yang X; Dai J; Li T; Zhang P; Ma Q; Li Y; Zhou J; Lei D
Oral Oncol; 2010 Oct; 46(10):755-60. PubMed ID: 20850374
[TBL] [Abstract][Full Text] [Related]
35. EMMPRIN (CD 147) is a central activator of extracellular matrix degradation by Chlamydia pneumoniae-infected monocytes. Implications for plaque rupture.
Schmidt R; Redecke V; Breitfeld Y; Wantia N; Miethke T; Massberg S; Fischel S; Neumann FJ; Schömig A; May AE
Thromb Haemost; 2006 Jan; 95(1):151-8. PubMed ID: 16543974
[TBL] [Abstract][Full Text] [Related]
36. Early events of overused supraspinatus tendons involve matrix metalloproteinases and EMMPRIN/CD147 in the absence of inflammation.
Attia M; Huet E; Gossard C; Menashi S; Tassoni MC; Martelly I
Am J Sports Med; 2013 Apr; 41(4):908-17. PubMed ID: 23404084
[TBL] [Abstract][Full Text] [Related]
37. Expression of extracellular matrix metalloproteinase inducer glycosylation and caveolin-1 in healthy and inflamed human gingiva.
Wang J; Yang D; Li C; Shang S; Xiang J
J Periodontal Res; 2014 Apr; 49(2):197-204. PubMed ID: 23647605
[TBL] [Abstract][Full Text] [Related]
38. Upregulation of EMMPRIN after permanent focal cerebral ischemia.
Zhu W; Khachi S; Hao Q; Shen F; Young WL; Yang GY; Chen Y
Neurochem Int; 2008 May; 52(6):1086-91. PubMed ID: 18164515
[TBL] [Abstract][Full Text] [Related]
39. Differential expression of extracellular matrix metalloproteinase inducer (CD147) in normal and ulcerated corneas: role in epithelio-stromal interactions and matrix metalloproteinase induction.
Gabison EE; Mourah S; Steinfels E; Yan L; Hoang-Xuan T; Watsky MA; De Wever B; Calvo F; Mauviel A; Menashi S
Am J Pathol; 2005 Jan; 166(1):209-19. PubMed ID: 15632013
[TBL] [Abstract][Full Text] [Related]
40. Receptor activator of NF-kappaB ligand enhances breast cancer-induced osteolytic lesions through upregulation of extracellular matrix metalloproteinase inducer/CD147.
Rucci N; Millimaggi D; Mari M; Del Fattore A; Bologna M; Teti A; Angelucci A; Dolo V
Cancer Res; 2010 Aug; 70(15):6150-60. PubMed ID: 20631064
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]